Liquidia: Ruling Reinforces Clear Path for FDA to Issue Final Decision on Amended NDA for Yutrepia to Treat Both PAH and PH-ILD >LQDA
Liquidia: Ruling Reinforces Clear Path for FDA to Issue Final Decision on Amended NDA for Yutrepia to Treat Both PAH and PH-ILD >LQDA
Liquidia：裁決強化FDA就修訂新藥申請(Yutrepia)治療包括肺動脈高壓和肺源性間質性肺疾病的最終決定之明確途徑>LQDA
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊